ARAna Maria Reis

Ana Maria Reis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Maria Reis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Temperate Bacterial Viruses as Double-Edged Swords in Bacterial Warfare

    by João Alves Gama, Ana Maria Reis, Iolanda Domingues, Helena Mendes-Soares, Ana Margarida Matos, Francisco Dionisio

    It has been argued that bacterial cells may use their temperate viruses as biological weapons. For instance, a few bacterial cells among a population of lysogenic cells could release the virus and kill susceptible non-lysogenic competitors, while their clone mates would be immune. Because viruses replicate inside their victims upon infection, this process would amplify their number in the arena. Sometimes, however, temperate viruses spare recipient cells from death by establishing themselves in a dormant state inside cells. This phenomenon is called lysogenization and, for some viruses such as the λ virus, the probability of lysogenization increases with the multiplicity of infection. Therefore, the amplification of viruses leads to conflicting predictions about the efficacy of temperate viruses as biological weapons: amplification can increase the relative advantage of clone mates of lysogens but also the likelihood of saving susceptible cells from death, because the probability of lysogenization is higher. To test the usefulness of viruses as biological weapons, we performed competition experiments between lysogenic Escherichia coli cells carrying the λ virus and susceptible λ-free E. coli cells, either in a structured or unstructured habitat. In structured and sometimes in unstructured habitats, the λ virus qualitatively behaved as a “replicating toxin”. However, such toxic effect of λ viruses ceased after a few days of competition. This was due to the fact that many of initially susceptible cells became lysogenic. Massive lysogenization of susceptible cells occurred precisely under the conditions where the amplification of the virus was substantial. From then on, these cells and their descendants became immune to the λ virus. In conclusion, if at short term bacterial cells may use temperate viruses as biological weapons, after a few days only the classical view of temperate bacterial viruses as parasitic agents prevails.


  • Open Access

    Pervasive Sign Epistasis between Conjugative Plasmids and Drug-Resistance Chromosomal Mutations

    by Rui F. Silva, Sílvia C. M. Mendonça, Luís M. Carvalho, Ana M. Reis, Isabel Gordo, Sandra Trindade, Francisco Dionisio

    Multidrug-resistant bacteria arise mostly by the accumulation of plasmids and chromosomal mutations. Typically, these resistant determinants are costly to the bacterial cell. Yet, recently, it has been found that, in Escherichia coli bacterial cells, a mutation conferring resistance to an antibiotic can be advantageous to the bacterial cell if another antibiotic-resistance mutation is already present, a phenomenon called sign epistasis. Here we study the interaction between antibiotic-resistance chromosomal mutations and conjugative (i.e., self-transmissible) plasmids and find many cases of sign epistasis (40%)—including one of reciprocal sign epistasis where the strain carrying both resistance determinants is fitter than the two strains carrying only one of the determinants. This implies that the acquisition of an additional resistance plasmid or of a resistance mutation often increases the fitness of a bacterial strain already resistant to antibiotics. We further show that there is an overall antagonistic interaction between mutations and plasmids (52%). These results further complicate expectations of resistance reversal by interdiction of antibiotic use. Bacteria can become resistant to antibiotics by spontaneous mutation of chromosomal genes or through the acquisition of horizontally mobile genetic elements, mainly conjugative plasmids. Plasmid-borne resistance is widespread among bacterial pathogens. Plasmids generally entail a cost to the host, associated with the replication and maintenance of the genetic element and with the expression of its genes. Therefore, in the absence of antibiotic, both plasmids and resistance mutations are often deleterious and confer a fitness cost to the cell. Here we studied epistatic interactions between five natural conjugative plasmids and ten chromosomal mutations conferring resistance to three types of antibiotics, making a total of 50 different combinations of chromosomal mutations and conjugative plasmids. We show that sometimes plasmids confer an advantage to bacterial strains carrying resistance mutations in their chromosome. This occurs in 32% (16 out of 50) of tested combinations. Furthermore, in 5 out of 50 plasmid-mutations combinations studied (10%), we observed an increased fitness when a plasmid-bearing bacterial cell acquires a drug-resistant mutation. These examples of sign epistasis are highly unexpected. This work explains, at least in part, how multidrug resistance evolved so rapidly.